Abstract:Abstract Chalcones compounds have been investigated to exhibit anticancer activity through various physiological modes of action. In order to develop chalcone compounds with novel anticancer-related modes of action, diverse chalcone compounds were designed and synthesized. Variously substituted poly-methoxy chalcone compounds 1 – 17 were prepared, and their structures were identified using high-resolution mass spectrometry (HR/MS) and nuclear magnetic resonance (NMR) experiments. Long-term survival clonogenic assay was applied to evaluate their anti-cancer abilities and revealed that their GI50 values ranged between 1.33 and 172.20 μM. When MCF-7SC cells were treated with various concentrations of compound 14 , reduced cell viability and induced apoptosis in MCF-7SC cells were observed in a dose-dependent manner. Wound healing assay demonstrated that compound 14 prevented the MCF7-SC migrated cells at non-lethal concentrations after 12 and 24 h of exposure. The efficiency of compound 14 on the levels of Epithelial-mesenchymal transition (EMT) markers was accessed by the western blot analysis. For the concrete understanding of anticancer properties at the molecular level, in vitro kinase assays on 12 cancer related proteins were carried out. Glycogen synthase kinase 3 beta (GSK3β) was most effectively inhibited by compound 14 with 89% inhibitory activity at 10 μM against GSK3β. The binding mode of compound 14 with GSK3β was reinforced through in silico experiments, which demonstrated compound 14 binds with GSK3β at binding affinity ranged between − 7.5 kcal/mol and − 6.8 kcal/mol. SwissADME analysis provided the druggability and leadlikeness of compound 14 , which unveiled drug development possibilities of chalcone compound 14 .

Elementary Study of the Effect of Chalcone on Cellular Biological Behavior of Human Stomach Cancer BGC823

Antiproliferative Evaluation in Vitro of a New Chalcone Inducing Apoptosis by ROS Generation Against MGC-803 Cells

Apoptosis of SGC7901 Gastric Cancer Cell Induced by Cyanidin-3-glucoside

Influence of Curcumin,Glyinflanins and Chalcone on Biological Actions of Human MGC-803

In Vitro Anti-Cancer Activity of Chamaejasmenin B and Neochamaejasmin C Isolated from the Root of Stellera Chamaejasme L

Synthesis and Biological Evaluation of Amino Chalcone Derivatives as Antiproliferative Agents

Design, Synthesis, anticancer evaluation and in silico studies of 2,4,6-trimethoxychalcone derivatives

Anti-proliferative and Apoptotic Effects of S1, a Tetrandrine Derivative, in Human Gastric Cancer BGC-823 Cells

Stellera Chamaejasme Induced Apoptosis of HL-60 Cells and Regulated Expression of Bcl-2 Protein in SGC-7901 Cells

Synthesis and biological evaluation of bis-chalcone conjugates containing lysine linker as potential anticancer agents

Involvement of Topoisomerase III in Telomere-Telomere Recombination*

A novel chalcone derivative S17 induces apoptosis through ROS dependent DR5 up-regulation in gastric cancer cells

LOCAL CHEMICAL ENVIRONMENTS AND THE PHONON PARTIAL DENSITIES OF STATES OF 57FE IN 57FE3AL

Design, synthesis, and biological evaluation of chalcones for anticancer properties targeting glycogen synthase kinase 3 beta

A flavonoid compound from Chrysosplenium nudicaule inhibits growth and induces apoptosis of the human stomach cancer cell line SGC-7901

Synthesis, characterization, and anticancer activity of syringaldehyde-derived chalcones against female cancers

Synthesis, Characterization, Antioxidant, and Anticancer Activity against Colon Cancer Cells of Some Cinnamaldehyde-Based Chalcone Derivatives

Study of Epigallocatechin - 3 - Gallate to SW480 and LoVo Colorectal Cancer Cells

Synthesis and Anti-Cancer Activity Evaluation of Novel Prenylated and Geranylated Chalcone Natural Products and Their Analogs.

Chelerythrine Chloride from Macleaya Cordata Induces Growth Inhibition and Apoptosis in Human Gastric Cancer Bgc-823 Cells

Synthesis and Antiproliferative Effect of 3,4,5-Trimethoxylated Chalcones on Colorectal and Prostatic Cancer Cells